OctoPlus said that the undisclosed contract value will make a material contribution to its’ annual revenues.
As per the contract terms, OctoPlus is expected to perform clinical manufacturing for the client’s product candidate.
OctoPlus provides formulation development and clinical material manufacturing services to biotech and pharmaceutical companies worldwide.
In addition OctoPlus offers its clients drug delivery technologies for the development of controlled release versions of existing or new drugs.